FSD BIO LABS · Product artwork
Studied for growth hormone release and growth hormone secretagogue signalling.
20 vials available
Full prepaid by UPI includes free delivery. COD requires 5% advance and a 1.5% delivery fee. Payment details
See delivery information and return conditions before ordering. Your final total is shown at checkout.
COA not yet available for this strength
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
Ipamorelin is a synthetic peptide classified as a growth hormone secretagogue, meaning it can stimulate growth hormone release in experimental systems. Research investigates its receptor activity and endocrine responses.
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Foundational pharmacology examined growth-hormone release and selectivity in experimental systems. Hormone responses do not establish muscle growth, fat loss or anti-ageing effects.
Read sourceThis randomised trial examined postoperative bowel recovery. It found no significant difference from placebo in the main or secondary efficacy analyses and does not support muscle-growth or recovery claims.
Read sourceIPAMORELIN is currently listed in 10 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
No laboratory report is currently published for this compound. Request the available documentation before relying on any batch-specific measurement. A scientific paper is not a substitute for a COA.
The references discuss the material and experimental conditions in those studies. They do not verify the identity, purity, quantity or suitability of this catalogue vial. Review the study limitations and the available batch documentation separately.
A CJC and ipamorelin blend intended for growth hormone signalling research.
Studied for melanocortin signalling and sexual desire responses.
Studied for growth hormone signalling and changes in visceral abdominal fat.
Studied for GHRH signalling and growth hormone/IGF-1 responses.